What Sinoway Industrial Co., Ltd. does

Sinoway Industrial Co., Ltd. is a privately held Chinese pharmaceutical and healthcare supply chain company founded in 1987 and headquartered in Xiamen, Fujian Province. The company operates as a B2B exporter and sourcing intermediary for Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, healthcare and food supplement ingredients (NMN, glutathione, NAD, Alpha GPC), cosmetic raw materials, peptide compounds (including GLP-1 receptor agonists such as Tirzepatide and Semaglutide), prostaglandin derivatives, plant extracts, and pharmaceutical packaging products. Sinoway also serves as the China office of Swiss-based FISCHER Chemical A.G., handling project and supply chain services for that entity.

The business operates a hybrid trading-plus-CDMO model. Manufacturing is outsourced to a network of Chinese partner factories compliant with Chinese and international GMP and ICH Q7 standards, while analytical testing is provided through partnerships with Chinese universities and testing institutes equipped with HPLC, LC-MS, GC, GCMS, and UV instrumentation. The CDMO service line handles custom development and manufacturing of advanced intermediates and new compounds under confidentiality agreements. Quality credentials include ISO9001:2015, SGS audit, HALAL, and Kosher certifications.

Revenue mechanics are anchored by direct sales to enterprise pharmaceutical buyers, with pricing negotiated on a per-inquiry basis for bulk orders. Customer acquisition relies heavily on annual participation in industry exhibitions — CPhI Worldwide, CPhI Japan, CPhI China, and Supply Side West — supplemented by a multilingual website (10 languages) and active social media presence. The company claims approximately 1,700 overseas customers across markets including the USA, Canada, Japan, South Korea, Switzerland, Germany, and Hong Kong, with named tier-1 relationships including Novartis, TEVA, Daito, and Sumitomo Seika. Headcount is reported at 29 employees, consistent with a lean sales-trading structure rather than a vertically integrated manufacturer.

Name

Sinoway Industrial Co., Ltd.

Legal name

Sinoway Industrial co., ltd.

Website

https://china-sinoway.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

Sinoway Industrial Co., Ltd. is a Chinese B2B exporter and CDMO founded in 1987, supplying pharmaceutical APIs, intermediates, peptide compounds, supplement ingredients, and cosmetic raw materials to global drug, nutraceutical, and personal care manufacturers through a 29-person sales organization and Chinese partner factory network.

Ownership category

akta.pro rank

Product category

Pharmaceutical Ingredients Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Pharmaceutical ingredients
• Active pharmaceutical ingredients
• Pharmaceutical intermediates
• Peptide compounds
• CDMO services

Headquarters

HQ city

Xiamen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. API and Pharmaceutical Intermediate Export: Export of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates to global pharmaceutical companies. The company specializes in manufacturing and exporting APIs, pharmaceutical intermediates, and related chemical compounds.
2. Custom Development and Manufacturing (CDMO): Custom development and manufacturing services for advanced intermediates and new compounds with special high quality requirements. Services include R&D to full-scale production under confidentiality agreements.
3. Health and Food Supplement Ingredients: Supply of healthcare and food supplement ingredients including NMN, glutathione, NAD, and other bioactive compounds for nutritional supplement manufacturers.
4. Cosmetic Raw Materials: Supply of cosmetic raw materials including peptides, botanical extracts, and active ingredients for cosmetics manufacturers globally.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Sinoway manufactures, exports, and custom-develops pharmaceutical and healthcare chemical ingredients, including APIs (e.g., Spironolactone, Hydrocortisone, Sitagliptin), pharmaceutical intermediates, peptide series (Liraglutide, Tirzepatide, Semaglutide), prostaglandin derivatives, plant extracts, nano-encapsulated actives, and cosmetic raw materials, for pharmaceutical, supplement, and cosmetic manufacturers worldwide. The company also operates as a Contract Development and Manufacturing Organization (CDMO) providing one-stop custom synthesis from R&D to production under secrecy agreements, supported by GMP/ICH Q7 manufacturing partners and analytical testing (HPLC, LC-MS, GC, GCMS, UV).

Product overview

Sinoway Industrial Co., Ltd. is a pharmaceutical and healthcare supply chain company offering a diversified portfolio of products organized into eight main categories: APIs (Active Pharmaceutical Ingredients), Pharmaceutical Intermediates, Healthcare & Food Supplements, Cosmetic Raw Materials, Nano Active Series, Herbal Extract, Polypeptides, and Prostaglandin Series. The company also provides CDMO (Contract Development and Manufacturing Organization) services for custom development and manufacturing. Their product portfolio includes high-value compounds like Tirzepatide, Semaglutide, Orforglipron, and various peptides (Liraglutide, Octreotide, Linaclotide), wellness ingredients (NMN, Glutathione, NAD), cosmetic actives (Copper Tripeptide-1, Ectoin, Nanoactive formulations), and prostaglandin derivatives. The Nano Active Series offers enhanced-bioavailability versions of ingredients like Astaxanthin and Resveratrol using nano-encapsulation technology. The company serves global pharmaceutical companies and provides testing services including HPLC, LC-MS, GC, and GCMS throughout product development cycles.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Pharmaceutical active ingredients including Spironolactone 52-01-7 (potassium-sparing diuretic), Hydrocortisone 50-23-7 (corticosteroid), Sitagliptin 486460-32-6 (DPP-4 inhibitor for Type 2 diabetes), Losartan Potassium 124750-99-8 (antihypertensive API at 98.5% USP purity), and Orforglipron (oral GLP-1 receptor agonist for diabetes and obesity). Sold in bulk to pharmaceutical manufacturers worldwide; catalog spans cardiovascular, anti-inflammatory, antidiabetic, and metabolic disease therapies.
• Pharmaceutical Intermediates Specialized intermediates for pharmaceutical synthesis such as Paclitaxel side chain (201856-53-3), 1-Hydrazino-3-(methylthio)propan-2-ol Nifuratel impurity (14359-97-8), Pitavastatin calcium intermediate (147511-70-4), and (-)-Corey Lactone Benzoate (39746-00-4, 98% HPLC purity). Used by pharmaceutical manufacturers and custom synthesis programs as key building blocks in API production routes.
• Polypeptides / Peptide Series Peptide compounds including Liraglutide (GLP-1 receptor agonist for diabetes and weight management), Octreotide Acetate (somatostatin analog for acromegaly and gastrointestinal disorders), Linaclotide (guanylate cyclase-C agonist for IBS), Tirzepatide (GLP-1/GIP dual agonist for Type 2 diabetes and weight management), Semaglutide (GLP-1 receptor agonist), and Copper Tripeptide-1/GHK-Cu (99% HPLC, anti-aging cosmetic active). Sold to pharmaceutical and cosmetic manufacturers.
• Healthcare and Food Supplement Ingredients Nutraceutical and supplement-grade ingredients including NMN 1094-61-7 (99% HPLC purity for anti-aging and NAD+ boosting), L-Glutathione Reduced 70-18-8 (GMP, USP/EP, HALAL, DML compliant), NAD 53-84-9, Alpha GPC 28319-77-9 (99.7% HPLC for cognitive support), and S-Acetyl-L-Glutathione 3054-47-5 (bioavailable glutathione form). Supplied to dietary supplement and health product manufacturers globally.
• Cosmetic Raw Materials Cosmetic-grade ingredients for skincare and beauty product formulations including Ectoin 96702-03-3 (extremolyte providing cell protection and anti-aging properties), Sodium Azulene Sulfonate / Sodium Gualenate 6223-35-4, and Guaiazulene 489-84-9. Sold to cosmetic and personal-care manufacturers globally.
• Nano Active Series Nano-encapsulated active ingredients including Nanoactive Astaxanthin 472-61-7 (5% HPLC purity), Nanoactive Resveratrol (RES) 501-36-0, and NANOACTIVE LIFT. Designed for enhanced bioavailability in cosmetic and supplement applications using nano-encapsulation technology. Supplied to cosmetics and supplement manufacturers.
• Herbal Extract / Plant Extracts Plant-derived extracts used in nutraceutical and cosmetic formulations, including Rhodiola rosea extract 97404-52-9, Beta Carotene 7235-40-7, and Ginseng Extract (Ginsenosides) 90045-38-8. Supplied to health supplement and cosmetic manufacturers.
• Prostaglandin Series Prostaglandin derivatives used in pharmaceutical synthesis and research, including ((-)-Corey lactone 4-phenylbenzoate alcohol / BPCOD 31752-99-5, (-)-Corey Lactone Benzoate 39746-00-4 (98% HPLC), and Bimatoprost 155206-00-1 (prostaglandin analog for glaucoma and eyelash growth). Supplied to pharmaceutical researchers and manufacturers.
• CDMO (Contract Development and Manufacturing Organization) Services One-stop Contract Development and Manufacturing Organization service covering custom development and manufacturing from R&D through full-scale production, especially for advanced intermediates and new compounds with special high-quality requirements. Engagements are executed under secrecy agreements, leveraging Chinese manufacturing partners compliant with Chinese and international GMP regulation and ICH Q7 quality management, plus testing infrastructure (HPLC, LC-MS, GC, GCMS, UV) provided through partnerships with China's top analysis and testing centers, institutes, and universities.

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• FISCHER Chemical A.G.coreGTM or Marketing PartnerSinoway is the China office of FISCHER Chemical A.G, responsible for project and supply chain services. This partnership positions Sinoway as the exclusive representative for FISCHER Chemical's operations in China.
• China's Top Analysis and Testing Centers, Institutes, and UniversitiescoreStrategic or Co-development PartnerLong-term cooperation established with China's top analysis and testing centers, institutes and universities equipped with facilities for special chemical reactions and testing conditions including HPLC, LC-MS, GC, GCMS, UV, etc. These partnerships provide comprehensive testing services throughout the entire product development cycle.
• Chinese Manufacturing PartnerscoreStrategic or Co-development PartnerSinoway cooperates closely with Chinese factories that have advanced production equipment and experts with rich experience in organic chemistry, enzyme catalysis, fermentation processes. These factories strictly comply with both Chinese and international GMP regulation and ICH Q7 quality management specification.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Bachem: Leading Swiss peptide CDMO with proprietary solid-phase peptide synthesis at commercial scale; comparable because Sinoway lists peptide APIs (Tirzepatide, Semaglutide) but Bachem is the dominant specialized peptide manufacturer.
• WuXi AppTec / WuXi STA: China-headquartered global CDMO with API manufacturing and custom synthesis services; comparable as a Chinese pharma services platform, but operates at vastly larger scale with owned facilities and broader end-to-end capabilities.
• Qilu Pharmaceutical (API division): Diversified Chinese pharmaceutical manufacturer with API production capabilities serving both domestic and export markets; comparable in API supply model but much larger scale and integrated downstream.
• Teva API (TAPI): Teva's API division, one of the world's largest API manufacturers; comparable as a customer of Sinoway but operates at vastly larger scale with vertically integrated generic API production.

Direct peers

• Nanjing Goldtech Hi-Tech: Chinese API and intermediate supplier with export focus to regulated markets; comparable size, customer base, and product categories (small-molecule APIs and intermediates).
• Zhejiang Huahai Pharmaceutical: China-based API manufacturer and exporter serving global generic pharma, including antihypertensives and CNS APIs; closely comparable product mix and customer base (US, EU generic drugmakers).
• Xi'an Saina Pharmaceutical: Chinese supplier of pharmaceutical intermediates and specialty APIs with similar export-led model targeting global pharma buyers; highly comparable in scale, scope, and customer profile.
• Shanghai Acebright Pharmaceuticals: Chinese API and intermediate manufacturer with export focus on regulated markets; directly comparable as an SME-sized Chinese supplier of small-molecule APIs to global pharma.
• Polypeptide Group: Specialized peptide CDMO with manufacturing capability across GLP-1 and therapeutic peptides; a direct comparable if Sinoway is genuinely pursuing peptide supply rather than just catalog listing.

Others

• FISCHER Chemical A.G. Swiss chemical distributor of which Sinoway serves as the China office; comparable as a specialty chemical supplier, with a direct partnership relationship that makes it both peer and partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/sinowaychem
• YouTubeyoutube.com/channel/UC_09d31ZL0C6ViCXeFH0Mxw
• Facebookfacebook.com/sinowaychem
• LinkedInlinkedin.com/company/sinoway-industrial-co.-ltd.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sinoway Industrial Co., Ltd.